We assisted Change Healthcare with a large joint venture transaction with McKesson Corporation, successfully transitioning a number of Employee Retirement Income Security Act (ERISA) and non-ERISA plans for use by the new combined company. Services included adoption and restatement of new qualified and non-qualified plans, as well as advice regarding all transition-related issues, such as top heavy testing transition relief.
Large Joint Venture Transaction
You Also May Be Interested In:
Lead Counsel to POINT Biopharma Inc. in its Proposed SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
We represented Tractor Supply Company (Nasdaq: TSCO) in their agreement to acquire Orscheln Farm and Home, a family-owned farm and ranch retailer.
Defended clients against roughly $26 million in ACA employer mandate penalties